{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:35:16Z","timestamp":1793036116754,"version":"4.5.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Angioimmunoblastic T-cell lymphoma (AITL) is a major type of peripheral T-cell lymphoma (PTCL). To elucidate the clinicopathologic characteristics and prognosis of AITL in Japan, we retrospectively analyzed 207 patients with AITL. The median patient age was 67 years (range, 34-91 years), with 73% of patients older than 60 years. With a median follow-up of 42 months in surviving patients, 3-year overall survival (OS) was 54% and progression-free survival (PFS) was 38%. The International Prognostic Index (IPI) and the prognostic index for PTCL, not otherwise specified (PIT) were predictive for OS in this analysis. Multivariate analysis found that age older than 60 years, elevated white blood cell (WBC) and IgA levels, the presence of anemia and thrombocytopenia, and extranodal involvement at &gt; 1 site were significant prognostic factors for OS, and IgA, anemia, and mediastinal lymphadenopathy were significant prognostic factors for PFS. A novel prognostic model consisting of the prognostic factors for OS was successfully constructed. In conclusion, IPI and PIT were still useful for prognostication of AITL, and other factors, including those not used in IPI, such as IgA, anemia, WBC count, thrombocytopenia, and mediastinal lymphadenopathy, also significantly affected prognosis. Future investigations for IgA as a unique prognostic factor are warranted.<\/jats:p>","DOI":"10.1182\/blood-2011-08-374371","type":"journal-article","created":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T02:00:44Z","timestamp":1328234444000},"page":"2837-2843","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":125,"title":["Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan"],"prefix":"10.1182","volume":"119","author":[{"given":"Takashi","family":"Tokunaga","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Aichi Cancer Center, Nagoya, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Chihara","sequence":"additional","affiliation":[{"name":"Aichi Cancer Center, Nagoya, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Ichihashi","sequence":"additional","affiliation":[{"name":"Okazaki City Hospital, Okazaki, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Oshima","sequence":"additional","affiliation":[{"name":"Yokohama City University Medical Center, Yokohama, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsune","family":"Tanimoto","sequence":"additional","affiliation":[{"name":"Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Toyohashi Municipal Hospital, Toyohashi, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Isoda","sequence":"additional","affiliation":[{"name":"Nishigunma National Hospital, Shibukawa, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sakai","sequence":"additional","affiliation":[{"name":"Hiroshima University, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Nagano Red Cross Hospital, Nagano, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Ichinomiya Municipal Hospital, Ichinomiya, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Matsue","sequence":"additional","affiliation":[{"name":"Kameda General Hospital, Kamogawa, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Taniwaki","sequence":"additional","affiliation":[{"name":"Kyoto Prefectural University of Medicine, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadahiro","family":"Tamashima","sequence":"additional","affiliation":[{"name":"Seirei Hamamatsu General Hospital, Hamamatsu, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Saburi","sequence":"additional","affiliation":[{"name":"Oita Prefectural Hospital, Oita, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Masunari","sequence":"additional","affiliation":[{"name":"Chugoku Central Hospital, Fukuyama, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Naoe","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Aichi Cancer Center, Nagoya, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111807285979300_B1","article-title":"Angioimmunoblastic T-cell lymphoma.","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Dogan","year":"2008"},{"issue":"5","key":"2019111807285979300_B2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma.","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111807285979300_B3","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"issue":"25","key":"2019111807285979300_B4","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111807285979300_B5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hon.853","article-title":"Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas.","volume":"26","author":"Niitsu","year":"2008","journal-title":"Hematol Oncol"},{"issue":"7","key":"2019111807285979300_B6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/oxfordjournals.annonc.a059281","article-title":"Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group.","volume":"6","author":"Siegert","year":"1995","journal-title":"Ann Oncol"},{"issue":"1","key":"2019111807285979300_B7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2008.11.008","article-title":"A T cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts.","volume":"30","author":"Dullaers","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"2019111807285979300_B8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1182\/blood.V72.3.1000.1000","article-title":"Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma.","volume":"72","author":"Tobinai","year":"1988","journal-title":"Blood"},{"issue":"3","key":"2019111807285979300_B9","first-page":"392","article-title":"Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.","volume":"122","author":"Weiss","year":"1986","journal-title":"Am J Pathol"},{"issue":"11","key":"2019111807285979300_B10","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2019111807285979300_B11","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"issue":"14","key":"2019111807285979300_B12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project.","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111807285979300_B13","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"issue":"8","key":"2019111807285979300_B14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3324\/haematol.10864","article-title":"Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma.","volume":"92","author":"Roncador","year":"2007","journal-title":"Haematologica"},{"issue":"2","key":"2019111807285979300_B15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","article-title":"Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10.","volume":"99","author":"Attygalle","year":"2002","journal-title":"Blood"},{"issue":"7","key":"2019111807285979300_B16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","article-title":"Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma.","volume":"30","author":"Dorfman","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2019111807285979300_B17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1309\/AJCP62WRKERPXDRT","article-title":"Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma.","volume":"131","author":"Yu","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"2019111807285979300_B18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","article-title":"Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells.","volume":"30","author":"Dupuis","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2019111807285979300_B19","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.pas.0000173238.17331.6b","article-title":"Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified.","volume":"29","author":"Asano","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2019111807285979300_B20","volume-title":"WHO Handbook for Reporting Results of Cancer Treatment","author":"World Health Organization","year":"1979"},{"issue":"3","key":"2019111807285979300_B21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/archdermatol.2008.607","article-title":"Atypical linear IgA dermatosis revealing angioimmunoblastic T-cell lymphoma.","volume":"145","author":"Nassar","year":"2009","journal-title":"Arch Dermatol"},{"issue":"1","key":"2019111807285979300_B22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1346-8138.2001.tb00083.x","article-title":"Leukocytoclastic vasculitis with IgA deposits in angioimmunoblastic T cell lymphoma.","volume":"28","author":"Sugaya","year":"2001","journal-title":"J Dermatol"},{"issue":"1","key":"2019111807285979300_B23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ijc.10758","article-title":"Angioimmunoblastic T cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4.","volume":"103","author":"Lee","year":"2003","journal-title":"Int J Cancer"},{"issue":"5","key":"2019111807285979300_B24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3109\/10428191003721359","article-title":"Pretreatment total serum protein is a significant prognostic factor for the outcome of patients with peripheral T\/natural killer-cell lymphomas.","volume":"51","author":"Watanabe","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"16","key":"2019111807285979300_B25","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/12\/2837\/1350140\/zh801212002837.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/12\/2837\/1350140\/zh801212002837.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T07:37:01Z","timestamp":1574062621000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/12\/2837\/29826\/Retrospective-analysis-of-prognostic-factors-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,22]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,3,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-08-374371","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,22]]}}}